Anastasia Meligkounaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anastasia Meligkounaki has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alexandros Choromidis
Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, 70013 Heraklion, Crete, Greece
1 shared publication- Angela Giangrande
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
1 shared publication - Christos Delidakis
Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, 70013 Heraklion, Crete, Greece
1 shared publication - Chrysanthi Voutyraki
Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, 70013 Heraklion, Crete, Greece
1 shared publication - Emmanouil Athanasiadis
Medical Image and Signal Processing Laboratory, Department of Biomedical Engineering, University of West Attica, 12241 Athens, Greece
1 shared publication - Evanthia Zacharioudaki
Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, 70013 Heraklion, Crete, Greece
1 shared publication
Latest Publications
- Open Access
- 7 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (33)
Growth deregulation and interaction with host hemocytes contribute to tumor progression in a Drosophila brain tumor model
Tumors constantly interact with their microenvironment. Here, we present data on a Notch-induced neural stem cell (NSC) tumor in Drosophila, which can be immortalized by serial transplantation in adult hosts. This tumor arises in the larva by virtue of the ability of Notch to suppress early differentiation–promoting factors in NSC progeny. Guided by transcriptome data, we have addressed both tumor-intrinsic and microenvironment-specific factors and how they contribute to tumor growth and host demise. The growth promoting factors Myc, Imp, and Insulin receptor in the tumor cells are important for tumor expansion and killing of the host. From the host’s side, hemocytes, professional phagocytic blood cells, are found associated with tumor cells. Phagocytic receptors, like NimC1, are needed in hemocytes to enable them to capture and engulf tumor cells, restricting their growth. In addition to their protective role, hemocytes may also increase the host’s morbidity by their propensity to produce damaging extracellular reactive oxygen species.
- 7 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (33)
Open AccessGrowth deregulation and interaction with host hemocytes contribute to tumor progression in a Drosophila brain tumor model
Tumors constantly interact with their microenvironment. Here, we present data on a Notch-induced neural stem cell (NSC) tumor in Drosophila, which can be immortalized by serial transplantation in adult hosts. This tumor arises in the larva by virtue of the ability of Notch to suppress early differentiation–promoting factors in NSC progeny. Guided by transcriptome data, we have addressed both tumor-intrinsic and microenvironment-specific factors and how they contribute to tumor growth and host demise. The growth promoting factors Myc, Imp, and Insulin receptor in the tumor cells are important for tumor expansion and killing of the host. From the host’s side, hemocytes, professional phagocytic blood cells, are found associated with tumor cells. Phagocytic receptors, like NimC1, are needed in hemocytes to enable them to capture and engulf tumor cells, restricting their growth. In addition to their protective role, hemocytes may also increase the host’s morbidity by their propensity to produce damaging extracellular reactive oxygen species.